AXQ Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

AXQ Capital’s Portfolio RARE Stock Details RARE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$346K	Sell	23,031 -10,769	-32%	-$259K	0.05%	545
2026 Q2	$1.13M	Sell	33,800 -62,377	-65%	-$1.55M	0.12%	255
2026 Q1	$2.01M	Buy	+96,177	New	+$2.17M	0.26%	106
2025 Q2	–	Sell	-12,346	Closed	-$447K	–	742
2025 Q1	$447K	Sell	12,346 -10,731	-47%	-$446K	0.18%	215
2024 Q4	$971K	Buy	+23,077	New	+$1.14M	0.44%	65
2024 Q2	–	Sell	-14,600	Closed	-$682K	–	675
2024 Q1	$682K	Buy	+14,600	New	+$689K	0.16%	218

Other funds holding RARE

Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM

GW&K Investment Management Boston, Massachusetts $11.8B AUM 29.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $123B AUM 30.05% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Panagora Asset Management Boston, Massachusetts $33.2B AUM 43.67% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return

AXQ Capital's RARE Position: Q3 2026 in Review

AXQ Capital reduced its Ultragenyx Pharmaceutical (RARE) stake by 32% in Q3 2026, selling an estimated $259K and leaving 23,031 shares worth $346K. The position accounts for 0.05% of the portfolio, ranked #545.

AXQ Capital first reported a position in RARE in Q1 2024 and has held it in 6 quarters since. The position peaked at $2.01M in Q1 2026. 163 funds tracked by Wall St. Rank hold RARE as of Q3 2026.

AXQ Capital held 23,031 shares of Ultragenyx Pharmaceutical worth $346K as of Q3 2026.
AXQ Capital sold 10,769 Ultragenyx Pharmaceutical shares in Q3 2026, an estimated $259K.
Ultragenyx Pharmaceutical made up 0.05% of AXQ Capital's portfolio in Q3 2026, its #545 holding.
AXQ Capital first reported a position in Ultragenyx Pharmaceutical in Q1 2024 and has held it in 6 quarters since.
AXQ Capital's Ultragenyx Pharmaceutical position peaked at $2.01M in Q1 2026.
163 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.

Based on AXQ Capital's 13F filing for Q3 2026, filed 12 Nov 2026.